Home > Cashflow Statement > INDOCO REMEDIES

INDOCO REMEDIES
Cash Flow from Operating Activities

    Back to Cashflow Statement
INDOCO REMEDIES is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results

INDOCO REMEDIES Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Operating Activities ₹95 Cr₹155 Cr₹179 Cr₹174 Cr₹82 Cr

What is the latest Cash Flow from Operating Activities ratio of INDOCO REMEDIES ?

The latest Cash Flow from Operating Activities ratio of INDOCO REMEDIES is ₹95 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Operating Activities
Mar2025₹95 Cr
Mar2024₹155 Cr
Mar2023₹179 Cr
Mar2022₹174 Cr
Mar2021₹82 Cr

How is Cash Flow from Operating Activities of INDOCO REMEDIES Trending?

Years Cash Flow from Operating Activities % Change
Mar2025 ₹95 Cr
-38.91
Mar2024 ₹155 Cr
-13.11
Mar2023 ₹179 Cr
2.88
Mar2022 ₹174 Cr
111.41
Mar2021 ₹82 Cr -

Compare Cash Flow from Operating Activities of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹2,044.9 Cr 0.6% -5.1% -25.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹456,114.0 Cr -1.2% -2.2% 15.8% Stock Analytics
DIVIS LABORATORIES ₹227,958.0 Cr 1% 16.3% 39.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹189,990.0 Cr 3.2% -0.8% 38.6% Stock Analytics
CIPLA ₹116,141.0 Cr -0.9% 1.6% -9.3% Stock Analytics
DR REDDYS LABORATORIES ₹98,604.4 Cr -1.7% -0.1% -6.5% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

0.6%

-5.1%

-25.9%

SENSEX

-0.7%

0.1%

-3.4%


You may also like the below Video Courses